Amid Reports of Infant Deaths, FTC Cracks Down on Homeopathy While FDA Investigates

JAMA. 2017 Feb 28;317(8):793-795. doi: 10.1001/jama.2016.19090.
No abstract available

MeSH terms

  • Belladonna Alkaloids / adverse effects*
  • Humans
  • Infant
  • Infant, Newborn
  • Materia Medica / adverse effects*
  • Patient Safety
  • Tooth Eruption*
  • United States
  • United States Food and Drug Administration

Substances

  • Belladonna Alkaloids
  • Materia Medica